January 25, 2018
Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares
Media
January 23, 2018
Altimmune Announces Notice of Allowance on Patent Covering Use of NasoShield in the U.S.
January 23, 2018
Onxeo Provides Update on Litigation with SpeBio/SpePharm
January 23, 2018
Nexstim Plc receives R&D loan from Business Finland
January 23, 2018
Emil Billbäck appointed CEO of BONESUPPORT
January 23, 2018
Strongbridge Biopharma plc Announces Proposed Public Offering of 5 Million Ordinary Shares
January 22, 2018
PUBLICATION HIGHLIGHTS A NOVEL CERAMENT® CARRIER WITH BONE ACTIVE AGENTS ENHANCING BONE FORMATION
January 18, 2018
Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent Covering RECORLEV™ (levoketoconazole) for the Treatment of Cushing’s Syndrome
January 18, 2018
Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent Covering RECORLEV™ (levoketoconazole) for the Treatment of Cushing’s Syndrome
January 17, 2018
Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris